investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Programmable DNA Binding Oligomers for Control of Transcription
Peter B Dervan
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Peter B Dervan
California Institute of Technology
Pasadena, United States
Related projects
Clinton Kylie Matson
Exploiting the Genomic Programs Underlying AR-Independent Prostate Cancer
Prostate
Pathology
Shahriar Koochekpour
Metabotropic Glutamate Receptor 1 in African American Prostate Cancer
Prostate
Michael Karin
IKK <alpha> and the Control of Prostate Cancer Metastasis
Prostate
Pathology
Bingcheng Wang
EphA2 kinase in prostate cancer
Prostate
William Figg
Clinical Pharmacogenetics
Prostate
Pathology
Brett Stewart Carver
Defining Response and Resistance to PI3K and AR inhibition in Prostate Cancer
Prostate
Scott M Dehm
AR Gene Rearrangements and AR Signaling in Prostate Cancer
Prostate
Pathology
William Figg
Development of Angiogenesis Inhibitors
Prostate
Dhyan Chandra
Hsp60 regulation of apoptosis in prostate cancer
Prostate
